Moderna held an analyst day on Nov. 12 at its Marlborough manufacturing facility, the site of production of its personalized oncology treatment, intismeran. Shares fell 7%.
The stellar efficacy and safety profile of Moderna's covid vaccine offered rapid validation of the firm's mRNA technology.
Moderna's Alexion partnership was terminated in 2017 after failure to find a safe but effective dose for the lead program, which could foreshadow difficulty finding a therapeutic window beyond low-dose vaccine programs.
Metric | MRNA | BNTX | PFE |
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 13.26 |
Price/Book Value | 13.67 | 1.05 | 1.85 |
Price/Sales | 36.40 | 7.57 | 2.60 |
Price/Cash Flow | — | — | 11.18 |
Metric | MRNA | BNTX | PFE |
|---|---|---|---|
Quick Ratio | 3.34 | 8.43 | 1.00 |
Current Ratio | 3.62 | 8.55 | 1.42 |
Interest Coverage | −49.00 | — | 2.39 |
Metric | MRNA | BNTX | PFE |
|---|---|---|---|
Return on Assets (Normalized) | −20.21% | −3.31% | 8.49% |
Return on Equity (Normalized) | −31.30% | −3.78% | 19.73% |
Return on Invested Capital (Normalized) | −27.15% | −4.37% | 12.71% |
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|n^F^zMj | LOCK|K$c$& | $138B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|^Fgm<j | LOCK|^D@$P | $98B | |||
| argenx SE ADR ARGX | LOCK|^%<g!l@ | LOCK|tr | $62B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|p%GnH@@ | LOCK|cf | $50B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|m>Yw<nb | LOCK|??Drb | $31B | |||
| Incyte Corp INCY | LOCK|zvrNx& | LOCK|>c@ | $25B | |||
| BioNTech SE ADR BNTX | LOCK|g<%>h^ | LOCK|V&W | $21B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|V#k>#%s | LOCK|>d#l | $21B | |||
| Jazz Pharmaceuticals PLC JAZZ | LOCK|#T<QY! | LOCK|J% | $15B |
United States